Clinical Trial Biorepository & Archiving Market to Reach USD 13.7 Billion by 2034 at a 10.9% of CAGR, Driven by Tech-Enabled Storage & Compliance

The global clinical trial biorepository and archiving solutions market is projected to increase from USD 4,877.7 million in 2024 to $13.7 billion by 2034, growing at a CAGR of 10.9% during the forecast period. The industry generated USD 4,398.2 million in revenue in 2023 and is experiencing rapid growth due to technological advancements and stringent regulatory guidelines.
Request a Sample Copy of This Report Now: – https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373735
Key Market Growth Drivers:
- Advancements in Biorepository Technology – Integration of remote monitoring, automated sample tracking, and digital archiving enhances efficiency and data integrity.
- Increasing Volume of Clinical Trials – The rise in personalized medicine, oncology research, and biologics development is fueling demand for secure, long-term sample storage.
- Regulatory & Compliance Standards – The National Cancer Institute (NCI) guidelines provide best practices for federally funded research institutions, driving quality assurance and standardization.
- Emphasis on Quality & Accreditation – Compliance with CAP (College of American Pathologists) and ISO standards ensures biorepositories meet strict accreditation and operational excellence criteria.
Industry Trends: Digital Transformation & Remote Operations
- AI-Powered Biobanking – Artificial intelligence (AI) is optimizing sample categorization, retrieval, and quality control.
- Cloud-Based Data Archiving – Secure cloud platforms are revolutionizing long-term storage, remote access, and collaboration in global clinical trials.
- Regenerative Medicine & Genomic Research – The rise in stem cell banking, genomic studies, and precision medicine is increasing the need for sophisticated biorepository solutions.
Future Outlook: Demand for Secure, Tech-Driven Biorepositories
As clinical trial volumes rise and biobanking technology evolves, pharmaceutical companies, CROs (contract research organizations), and research institutions are expected to expand their biorepository capabilities. The adoption of automation, AI, and compliance-driven storage solutions will continue shaping the market’s growth.
Market Dynamics
- The market is anticipated to exhibit a year-over-year growth rate of 10.9% in 2024, driven by the aforementioned factors.
- The integration of technology into biorepository operations allows for standardized workflows, resource sharing, and improved collaboration among research networks.
Key Players of the Clinical Trial Biorepository & Archiving Solution Industry
- Brooks Life Science
- Patheon
- Precision for Medicine, Inc.
- Medpace
- LabCorp Drug Development
- ATCC
- Q2 Solutions
- Labconnect
- Charles River Laboratories
- Cell&Co BioServices
Clinical Trial Biorepository Market Segmentation
By Product Type:
In terms of product type, the industry is classified into preclinical products and clinical products.
By Phase:
In terms of phase, the industry is segregated into phase I, phase II, phase III, and phase IV.
By Application:
In terms of application, the market is segmented into biorepository services and archiving solution services.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, Middle East and Africa have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Editor Details
-
Company:
- MARKITWIRED
- Website: